首页> 外文OA文献 >Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)

【2h】

Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)

机译：吉非替尼与安慰剂作为局部晚期或转移性非小细胞肺癌患者的维持治疗的III期随机，安慰剂对照，平行组研究的最终总体生存结果（INFORM； C-TONG 0804）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhao Hongyun; Fan Yun; Ma Shenglin; Song Xiangqun; Han Baohui; Cheng Ying; Huang Cheng; Yang Shujun; Liu Xiaoqing; Liu Yunpeng; Lu Shun; Wang Jie; Zhang Shucai; Zhou Caicun; Wang Mengzhao; Zhang Li;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 吉非替尼治疗局部晚期或转移性非小细胞肺癌患者疗效及生存的临床预测因素——两项Ⅱ期临床研究的综合分析 [J] . 赵媛媛, 张阳, 赵洪云, 癌症（英文版） . 2009,第006期
2. Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (INFORM; C-TONG 0804) [J] . Zhao Hongyun, Fan Yun, Ma Shenglin, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第4期

机译：最终整体生存结果来自III期，随机，安慰剂对照，并行群体研究吉非替尼与安慰剂作为局部晚期或转移性非小细胞肺癌患者的维护治疗（通知; C-Tong 0804）
3. Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (INFORM; C-TONG 0804) [J] . Zhao Hongyun, Fan Yun, Ma Shenglin, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第4期

机译：吉非替尼与安慰剂作为局部晚期或转移性非小细胞肺癌患者的维持治疗的III期随机，安慰剂对照，平行组研究的最终总体生存结果（INFORM; C-TONG 0804）
4. Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): A multicentre, double-blind randomised phase 3 trial [J] . ZhangL., MaS., SongX., The lancet oncology . 2012,第5期

机译：吉非替尼与安慰剂在局部晚期或转移性非小细胞肺癌患者中的维持治疗（INFORM; C-TONG 0804）：一项多中心，双盲，随机3期试验
5. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
6. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
7. INFORM; C-TONG 0805: A multicenter double blind randomized phase III trial of maintenance gefitinib compared to placebo in advanced non-small cell lung cancer [O] . Thomas E. Stinchcombe 2012

机译：通知; C-TONG 0805：吉非替尼维持治疗与安慰剂治疗晚期非小细胞肺癌的多中心双盲随机III期试验
8. First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study [O] . Yang James Chih-Hsin, Srimuninnimit Vichien, Ahn Myung-Ju, 2016

机译：一线培美曲塞加顺铂再加吉非替尼维持治疗与吉非替尼单药治疗在患有局部晚期或转移性非鳞状非小细胞肺癌的东亚非吸烟患者中：一项随机第3期研究的最终总生存率

Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)

著录项

引文网络

相似文献

相关主题

期刊订阅